Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 50(3): [102158], Abr. 2024. tab
Article in Spanish | IBECS | ID: ibc-232207

ABSTRACT

Introducción: La pandemia mundial por SARS-CoV-2 ha ocasionado un gran impacto en la vida de los adolescentes afectando el bienestar infanto-juvenil, sin embargo, existe escasa evidencia del efecto que ha tenido a nivel emocional en esta población. Objetivo: Explorar los conocimientos, percepciones y actitudes de los jóvenes frente a la COVID-19 y el impacto provocado en el bienestar emocional. Material y método: Estudio observacional transversal y descriptivo, a partir de una encuesta realizada a alumnos de 16-20 años de cinco institutos del área metropolitana de Barcelona. Resultados: El estudio se efectuó sobre 291 encuestas. De los participantes, 56,7% fueron mujeres. La edad media fue de 16,8 años y la mediana de 17 años. Se detectó un mayor desconocimiento sobre la transmisión de la enfermedad. Las fuentes de información más utilizadas fueron las redes sociales. En cuanto al malestar emocional, destaca la preocupación por enfermar (64%), los problemas económicos familiares (46%), la ansiedad e irritabilidad (27%) y la apatía (26,5%). Se detectan diferencias entre géneros en cuanto a la preocupación (mujeres: 28,8%, hombres: 11,1%), tristeza (mujeres: 29,3%, hombres: 15,5%) y sensación de tener miedo (mujeres: 24,5%, hombres 11%). De los sujetos, 16,7% consultaron con un profesional de salud mental, siendo más frecuente en mujeres (23,8%, hombres: 7,4%). Conclusiones: La COVID-19 ha afectado el bienestar emocional de los adolescentes, sobre todo en la población femenina. Se detecta un mayor uso de las redes sociales para evitar el aislamiento social. Los resultados del estudio pueden ayudar a diseñar estrategias para evitar malestares futuros en el ámbito biopsicosocial.(AU)


Introduction: The worldwide pandemic of SARS-Cov2 has had a great impact on the lives of adolescents, affecting their health and well-being. There is little evidence of the emotional impact of the pandemic on adolescents. Objectiv: To explore the knowledge, perceptions, and attitudes of young people regarding COVID-19 and its impact on emotional well-being. Method: A cross-sectional observational and descriptive study based on a survey of students aged 16–20 from five high schools in Barcelona metropolitan area. Results: The study was carried out on 291 surveys. Females made up 56.7% of the population. The average age was 16.9 years. A greater lack of knowledge about the transmission of the disease was detected. The most frequently used sources of information were social networks. In terms of emotional distress, the most important aspects were worry about getting sick (64%), family financial problems (46%), anxiety and irritability (27%), and apathy (26.5%). Gender differences were detected in terms of worries (women: 28.8%; men: 11.1%), sadness (women: 29.3%, men: 15.5%), and feelings of fear (women: 24.5%; men: 11%). 16.7% of the participants consulted a mental health professional, with this being more common in women (women: 23.8%; men: 7.4%). Conclusions: COVID-19 has affected the emotional well-being of adolescents, especially the female population. It is necessary to implement emotional well-being strategies in early childhood to cope with possible stressful situations in daily life and avoid future mental health problems. There is a growing use of social media to combat social isolation. The results of the study hold the potential to strategies aimed at preempting forthcoming biopsychosocial distress.(AU)


Subject(s)
Humans , Male , Female , Adolescent , Mental Health , Adolescent Health , /psychology , Adolescent Behavior , Quarantine , Psychology, Adolescent , Cross-Sectional Studies , Epidemiology, Descriptive , Primary Health Care , /epidemiology , Surveys and Questionnaires , Spain
2.
Semergen ; 50(3): 102158, 2024 Apr.
Article in Spanish | MEDLINE | ID: mdl-38157749

ABSTRACT

INTRODUCTION: The worldwide pandemic of SARS-Cov2 has had a great impact on the lives of adolescents, affecting their health and well-being. There is little evidence of the emotional impact of the pandemic on adolescents. OBJECTIVE: To explore the knowledge, perceptions, and attitudes of young people regarding COVID-19 and its impact on emotional well-being. METHOD: A cross-sectional observational and descriptive study based on a survey of students aged 16-20 from five high schools in Barcelona metropolitan area. RESULTS: The study was carried out on 291 surveys. Females made up 56.7% of the population. The average age was 16.9 years. A greater lack of knowledge about the transmission of the disease was detected. The most frequently used sources of information were social networks. In terms of emotional distress, the most important aspects were worry about getting sick (64%), family financial problems (46%), anxiety and irritability (27%), and apathy (26.5%). Gender differences were detected in terms of worries (women: 28.8%; men: 11.1%), sadness (women: 29.3%, men: 15.5%), and feelings of fear (women: 24.5%; men: 11%). 16.7% of the participants consulted a mental health professional, with this being more common in women (women: 23.8%; men: 7.4%). CONCLUSIONS: COVID-19 has affected the emotional well-being of adolescents, especially the female population. It is necessary to implement emotional well-being strategies in early childhood to cope with possible stressful situations in daily life and avoid future mental health problems. There is a growing use of social media to combat social isolation. The results of the study hold the potential to strategies aimed at preempting forthcoming biopsychosocial distress.


Subject(s)
COVID-19 , Adolescent , Female , Humans , Male , Anxiety/epidemiology , Cross-Sectional Studies , RNA, Viral , SARS-CoV-2 , Young Adult
3.
Article in English | MEDLINE | ID: mdl-27638115

ABSTRACT

Infections caused by thermotolerant Campylobacter spp. and Salmonella spp. are the leading causes of human gastroenteritis worldwide. Wild birds can act as reservoirs of both pathogens. A survey was carried out to determine the prevalence, genetic diversity and antimicrobial resistance of thermotolerant Campylobacter and Salmonella in waterfowl used as decoys and wild raptors in Andalusia (Southern Spain). The overall prevalence detected for Campylobacter was 5.9% (18/306; CI95%: 3.25-8.52) in decoys and 2.3% (9/387; CI95%: 0.82-3.83) in wild raptors. Isolates were identified as C. jejuni, C. coli and C. lari in both bird groups. Salmonella was isolated in 3.3% (10/306; CI95%: 2.3-4.3) and 4.6% (18/394; CI95%: 3.5-5.6) of the decoys and raptors, respectively. Salmonella Enteritidis and Typhimurium were the most frequently identified serovars, although Salmonella serovars Anatum, Bredeney, London and Mikawasima were also isolated. Pulsed-field gel electrophoresis analysis of isolates showed higher genetic diversity within Campylobacter species compared to Salmonella serovars. Campylobacter isolates showed resistance to gentamicin, ciprofloxacin and tetracycline, while resistance to erythromycin and tetracycline was found in Salmonella isolates. The results indicate that both decoys and raptors can act as natural carriers of Campylobacter and Salmonella in Spain, which may have important implications for public and animal health.


Subject(s)
Bird Diseases/microbiology , Campylobacter Infections/veterinary , Campylobacter/genetics , Drug Resistance, Multiple, Bacterial/genetics , Genetic Variation , Raptors/microbiology , Salmonella Infections, Animal/microbiology , Salmonella/genetics , Animals , Animals, Wild/microbiology , Anti-Infective Agents/pharmacology , Bird Diseases/epidemiology , Campylobacter/drug effects , Campylobacter/isolation & purification , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Campylobacter Infections/transmission , Ciprofloxacin/pharmacology , Ducks/microbiology , Electrophoresis, Gel, Pulsed-Field , Erythromycin/pharmacology , Feces/microbiology , Geese/microbiology , Humans , Microbial Sensitivity Tests , Prevalence , Salmonella/drug effects , Salmonella/isolation & purification , Salmonella Infections, Animal/epidemiology , Salmonella Infections, Animal/transmission , Spain/epidemiology , Zoonoses
4.
Comp Immunol Microbiol Infect Dis ; 37(2): 115-21, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24462184

ABSTRACT

A cross-sectional study was performed to assess the occurrence of Campylobacter species and to identify potential associated risk factors for wild artiodactyl species in southern Spain. Campylobacter species were isolated in 55 of 363 (15.2%) faecal samples. Campylobacter was identified in faeces from wild boar (49/126; 38.9%), red deer (5/179; 2.8%) and mouflon (1/13; 7.7%) but not from fallow deer (0/45). The isolated Campylobacter species were identified as C. jejuni (2 isolates; 3.6%), C. coli (11 isolates; 20.0%) and C. lanienae (37 isolates; 67.3%). Five isolates (9.1%) could not be identified at the species level. This report is the first to describe C. lanienae infection in wild ruminant species. Resistance to erythromycin (4.8%), ciprofloxacin (37.5%), tetracycline (52.9%) and streptomycin (55%) were detected. C. lanienae presented a significantly higher number of susceptible isolates to ciprofloxacin and tetracycline than C. coli. Due to the low number of positive wild ruminants, a Generalised Estimating Equations model was only carried out for wild boar. The model indicated that the risk factors associated with Campylobacter infection were the density of wild boar (>10/100ha) (OR: 3.05; CI95%: 2.2-4.3), the presence of artificial waterholes (OR: 3.67; CI95%: 1.3-10.5) and the winter season (OR: 3.30; CI95%: 1.9-5.8). Campylobacter infection is widespread in wild boar populations in southern Spain. These findings suggest that wild artiodactyls, particularly wild boar, constitute a reservoir of Campylobacter species, including resistant and multi-resistant strains, which may be of public health concern.


Subject(s)
Campylobacter Infections/veterinary , Campylobacter coli/drug effects , Campylobacter jejuni/drug effects , Campylobacter/drug effects , Deer/microbiology , Drug Resistance, Multiple, Bacterial , Sus scrofa/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Campylobacter/isolation & purification , Campylobacter/physiology , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Campylobacter coli/isolation & purification , Campylobacter coli/physiology , Campylobacter jejuni/isolation & purification , Campylobacter jejuni/physiology , Cross-Sectional Studies , Disease Reservoirs , Feces/microbiology , Incidence , Microbial Sensitivity Tests , Risk Factors , Spain/epidemiology
5.
Comp Immunol Microbiol Infect Dis ; 35(6): 505-12, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22640550

ABSTRACT

A microbiological and epidemiological survey examining Campylobacter species-related infection in dogs from clinics in Cordoba (Southern Spain) was performed from May 2007 to March 2008. Three-hundred and six rectal swabs were taken from both ill and healthy dogs, and an epidemiological questionnaire was filled out. The isolated bacterial strains were identified by means of multiplex polymerase chain reaction (PCR). The prevalence factors for Campylobacter spp., C. jejuni and C. upsaliensis infection were determined by logistic regression. An antimicrobial susceptibility screening test was performed using the agar disk diffusion method. Campylobacter species were isolated from 102 samples. Forty strains (35.2%) were identified as Campylobacter jejuni, 60 strains (58.8%) as Campylobacter upsaliensis and two strains (2%) as Campylobacter spp. The sampling season was a prevalence factor for C. jejuni infection, while the age of the dog was a prevalence factor for Campylobacter spp. and C. upsaliensis infection. Enteric disease was a prevalence factor for Campylobacter spp., C. jejuni and C. upsaliensis infection. The antimicrobial susceptibility test indicated that gentamicin and erythromycin were the most effective antibiotics, with 97.8% and 88% strains sensitive to the antibiotics, respectively.


Subject(s)
Campylobacter Infections/veterinary , Campylobacter jejuni/drug effects , Campylobacter upsaliensis/drug effects , Dog Diseases/epidemiology , Multiplex Polymerase Chain Reaction/veterinary , Age Factors , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Campylobacter Infections/drug therapy , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Campylobacter jejuni/growth & development , Campylobacter upsaliensis/growth & development , Dog Diseases/drug therapy , Dog Diseases/microbiology , Dogs , Erythromycin/pharmacology , Erythromycin/therapeutic use , Female , Gentamicins/pharmacology , Gentamicins/therapeutic use , Male , Microbial Sensitivity Tests , Prevalence , Spain/epidemiology , Surveys and Questionnaires
9.
Am J Kidney Dis ; 29(4): 541-8, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9100042

ABSTRACT

Treatment with recombinant human erythropoietin (rHuEPO) has solved the problem of anemia in patients on dialysis. However, its application to predialysis patients has raised some doubts about its effects on the progression of renal disease and on blood pressure (BP) and hemodynamic regulation. We have prospectively studied over at least 6 months a group of 11 predialysis patients receiving rHuEPO treatment (initial dose, 1,000 U subcutaneously three times a week). Clinical assessment and biochemical and hematologic measurements were made once every 2 weeks. Twenty-four-hour ambulatory BP monitoring, echocardiography, and determination of neurohumoral mediators of hemodynamics were performed once every 3 months. An adequate hematologic response was found (hemoglobin, 11.7 +/- 0.4 g/dL v 9 +/- 0.3 g/dL) without changes in the progression of renal disease. A decrease in cardiac output and an increase in total peripheral resistance was seen as anemia improved. A trend toward decreased left ventricular (LV) thickness and a significant decrease in LV mass index (from 178.2 +/- 20.6 g/m2 to 147.3 +/- 20.6 g/m2) were observed. Blood pressure control did not improve; moreover, in some patients an increase in systolic values was detected by ambulatory BP. Casual BP remained seemingly stable. Sequential determinations of neurohumoral mediators of hemodynamic substances (endothelin, renin, norepinephrine, epinephrine, dopamine) failed to explain these results. Ambulatory BP reveals a worse control in some patients who were previously hypertensive and confirms the utility of this technique in the assessment of patients under erythropoietin treatment. The trend toward LV hypertrophy regression without improved BP control confirms the role of anemia among the multiple factors leading to LV hypertrophy in end-stage renal disease (ESRD), and opens therapeutic possibilities. Better control of BP may avoid a potential offsetting of beneficial effects that correcting anemia would have on the cardiovascular system.


Subject(s)
Anemia/therapy , Erythropoietin/therapeutic use , Hemodynamics , Kidney Failure, Chronic/physiopathology , Adult , Aged , Anemia/blood , Anemia/etiology , Blood Pressure , Catecholamines/blood , Echocardiography , Endothelin-1/blood , Female , Hemoglobins/analysis , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Middle Aged , Prospective Studies , Recombinant Proteins , Renal Dialysis , Renin/blood , Ventricular Function, Left
10.
Exp Nephrol ; 5(1): 95-9, 1997.
Article in English | MEDLINE | ID: mdl-9052854

ABSTRACT

In the absence of anemia, rats with nephrectomy-induced renal failure displayed a reduced activity of erythrocyte aminolevulinate dehydrase, increased blood porphyrin levels, and a plasma capacity to inhibit the activity of the erythrocyte aminolevulinate dehydrase in vitro. Even though it did increase hemoglobin and hematocrit levels, treatment with erythropoietin had no effect on the derangements of porphyrin metabolism. No abnormalities of the heme pathway were observed in liver tissue. Experimental chronic renal failure reproduced the same abnormalities of porphyrin metabolism usually detected in patients with end-stage renal disease.


Subject(s)
Kidney Failure, Chronic/enzymology , Porphobilinogen Synthase/metabolism , Porphyrins/blood , 5-Aminolevulinate Synthetase/metabolism , Animals , Creatinine/metabolism , Disease Models, Animal , Erythrocytes/enzymology , Heme/biosynthesis , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/surgery , Liver/enzymology , Male , Nephrectomy , Rats , Rats, Wistar
11.
Nephrol Dial Transplant ; 11(9): 1775-80, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8918621

ABSTRACT

BACKGROUND: The true incidence of lead (Pb) overload as a cause of chronic renal failure (CRF) is unknown. Also, it is unclear if CRF per se could generate an increment in the body Pb burden. Most studies of chronic Pb intoxication have been performed on cohorts or patients with a past history of occupational exposure. Therefore we studied the body Pb burden in CRF of known aetiology versus those patients with CRF with gout and hypertension of unclear aetiology without a past history of Pb exposure. In addition we studied patients diagnosed with essential hypertension. METHODS: We studied 296 patients lacking a past history of Pb exposure, who were subdivided into four groups: group I (n = 30), normal control subjects; group II (n = 104), patients with 'essential' hypertension and normal renal function; group III (n = 132), patients with CRF of uncertain aetiology in association with hypertension and/or gout, and group IV (n = 30), patients with CRF of known aetiology. The blood and urine Pb levels were assessed before and after an EDTA test. RESULTS: No abnormal test results were obtained for patients in groups I and IV. The EDTA test was abnormal in 16 patients (15.4%) in group II and in 74 patients (56.1%) in group III. A positive correlation was observed between plasma creatinine levels and post-EDTA urinary Pb in group III, but not in group I. No correlation regarding plasma creatinine and the duration of hypertension or gout were demonstrated. The bone Pb levels, measured in 12 patients with pathological EDTA test results, were positively correlated to the plasma creatinine levels. CONCLUSIONS: A high percentage of patients with gout, hypertension, and CRF have an excessive Pb burden, and about 15% of the patients diagnosed as 'essential' hypertensives also show high Pb burdens. It is remarkable that a history of overt Pb exposure was lacking in the whole study population.


Subject(s)
Hypertension/etiology , Kidney Failure, Chronic/etiology , Lead Poisoning/complications , Body Burden , Bone and Bones/metabolism , Chelating Agents , Edetic Acid , Gout/complications , Humans , Hypertension/complications , Kidney Failure, Chronic/complications , Lead/blood , Lead/metabolism , Lead/urine , Middle Aged
12.
Nephron ; 73(2): 280-5, 1996.
Article in English | MEDLINE | ID: mdl-8773356

ABSTRACT

Hematocrit increase with recombinant erythropoietin (rEPO) has been associated with increased progression of renal insufficiency in experimental models of renal mass reduction. The aim of the present study was to assess the effects of therapy with rEPO and various antihypertensives on the progression of chronic renal insufficiency and on arterial hypertension in an experimental model of renal mass reduction. Rats subjected to a two-thirds nephrectomy were randomly assigned to an untreated control group or to therapy with rEPO (subcutaneously, at an initial dose of 40 U/kg thrice weekly), rEPO plus verapamil (subcutaneously, 0.5 mg/kg/day), or rEPO plus enalapril (orally, 50 mg/l in the drinking water). Combining enalapril and rEPO therapy controlled systemic blood pressure (BP) and the increase in proteinuria. Glomerular injury, as assessed 16 weeks after renal ablation, was more marked in the animals treated with rEPO with or without either antihypertensive. The morphometric analyses showed greater glomerular tuft areas in the three groups receiving rEPO than in the controls. The glomerular tuft area was directly correlated with the rate of glomerulosclerosis. In about 11% of the rEPO-treated hypertensive rats, the lesions showed severe hypertensive vasculopathy; in the animals treated with rEPO plus enalapril, the lesions were less severe. We conclude that therapy with rEPO was associated to renal damage which could not be attenuated by enalapril despite controlling BP and proteinuria, and may have a nonhemodynamic cause. Therapy with rEPO might trigger lesions usually associated with severe arterial hypertension; concomitant therapy with enalapril attenuates hypertensive vasculopathy.


Subject(s)
Erythropoietin/pharmacology , Kidney/physiology , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Body Weight/drug effects , Calcium Channel Blockers/pharmacology , Creatinine/blood , Hematocrit , Male , Nephrectomy , Proteinuria/urine , Rats , Rats, Wistar , Recombinant Proteins , Vasodilation/drug effects
13.
Am J Kidney Dis ; 25(6): 918-23, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7771489

ABSTRACT

Renal endothelin-1 (ET-1) production is diminished in spontaneously hypertensive rats. An increase has been reported of renal ET-1 production associated with progression of renal disease in rats with reduced renal mass. The purpose of the present study was to investigate the evolution over time of the urinary ET-1 excretion in an experimental model of renal mass reduction not caused by renal infarction. Rats were subjected to 2/3 nephrectomy (right nephrectomy and resection of the lower left renal pole) and thereafter randomly assigned to a no-treatment control group or to treatment with recombinant erythropoietin, recombinant erythropoietin plus verapamil, or recombinant erythropoietin plus enalapril. The urinary ET-1 excretion was decreased by week 16 after nephrectomy as compared with healthy animals and with the levels 6 weeks after nephrectomy. The temporal evolution of urinary ET-1 excretion in the various groups of rats showed a trend toward decrease in all groups except the one receiving enalapril. The urinary ET-1 excretion correlated directly with creatinine clearance and inversely with tubulointerstitial damage. We observed an inverse correlation between urinary ET-1 excretion and arterial blood pressure 16 weeks after nephrectomy. These results indicate that renal ET-1 production decreases with the progression of renal disease and in relation with the severity of tubulointerstitial damage. The decrease in renal ET-1 production might contribute to the development and perpetuation of renal disease-associated arterial hypertension; this situation may be favorably modified by the use of enalapril.


Subject(s)
Endothelins/urine , Hypertension, Renal/urine , Kidney Diseases/urine , Kidney/metabolism , Animals , Enalapril/therapeutic use , Endothelins/metabolism , Erythropoietin/therapeutic use , Hypertension, Renal/drug therapy , Kidney Diseases/drug therapy , Male , Nephrectomy , Radioimmunoassay , Rats , Rats, Wistar , Recombinant Proteins/therapeutic use , Verapamil/therapeutic use
16.
Nephron ; 69(4): 472-5, 1995.
Article in English | MEDLINE | ID: mdl-7777115

ABSTRACT

We report a case of congenital magnesium-losing kidney with associated hypercalciuria and ocular derangements consisting of myopia, bilateral macular colobomata and bilateral papillary dysversion and hypoplasia. Our patient provides further evidence of the existence of an oculorenal syndrome associating abnormalities in the renal handling of magnesium and calcium, and myopia and chorioretinal disease.


Subject(s)
Calcium/urine , Eye Diseases/complications , Kidney Diseases/complications , Magnesium Deficiency/complications , Nephrocalcinosis/complications , Adult , Coloboma/complications , Female , Humans , Kidney Diseases/metabolism , Macula Lutea/abnormalities , Myopia/complications , Optic Disk/abnormalities , Syndrome
18.
Kidney Int ; 46(4): 1167-77, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7861713

ABSTRACT

Using invasive techniques we have studied various hemodynamic and gasometric parameters in the course of hemodialysis (HD) with different buffers in an animal model. HD sessions of 180 minutes at zero ultrafiltration were carried out on three groups of eight uremic dogs each, under anesthesia and constant mechanical ventilation. The three groups differed only in the buffer used: acetate (Group AC), equal proportions of DL-lactate and acetate (Group AC+LA), and bicarbonate (Group BC). No hemodynamic changes were seen in Group BC. In the AC and AC+LA groups we observed on minute 1 a decrease of the mean blood pressure (MBP) and of the systemic vascular resistances (SVR). These parameters returned to baseline values within the first 30 minutes in Group AC+LA. In Group AC the SVR also returned to baseline values after the minute 30, but the MBP remained below baseline throughout the study period, together with cardiac index and left ventricular stroke work index decreases. Only in Group AC did we see a flattening of the ventricular function curves. Only in this Group was there a decrease of the arterial oxygen pressure (PaO2) with an associated increase of the alveolo-arterial and arterio-venous O2 differences. The O2 consumption was not modified in any of the groups. Acetate as a single buffer induces hemodynamic instability through peripheral vasodilation and reduction of myocardial contractility. The myocardial depression induced by acetate, in its turn, causes a reduction in PaO2. The mixed acetate+lactate buffer is hemodynamically better tolerated than acetate as single buffer, as it induces only vasodilation.


Subject(s)
Hemodialysis Solutions , Hemodynamics , Oxygen/blood , Renal Dialysis/methods , Acetates/blood , Acetic Acid , Animals , Bicarbonates/blood , Buffers , Dogs , Hemodialysis Solutions/adverse effects , Hemodynamics/drug effects , Lactates/blood , Lactic Acid , Models, Biological , Myocardial Contraction/drug effects , Oxygen Consumption/drug effects , Renal Dialysis/adverse effects , Vasodilation/drug effects
20.
Chest ; 105(5): 1590-2, 1994 May.
Article in English | MEDLINE | ID: mdl-8181365

ABSTRACT

A 65-year-old woman with previously known rheumatoid arthritis and chronic renal failure of possible glomerular origin was admitted to the hospital because of hemoptysis and respiratory insufficiency. Antineutrophil cytoplasmic antibodies (ANCAs) with antimyeloperoxidase activity were detected in her serum. The lung biopsy specimen evidenced alveolar hemorrhage. Under immunosuppressive therapy with steroids and cyclophosphamide, the patient's condition improved both clinically and radiologically, and the ANCA became negative after 6 months' therapy.


Subject(s)
Arthritis, Rheumatoid/complications , Autoantibodies/analysis , Hemorrhage/etiology , Lung Diseases/etiology , Aged , Antibodies, Antineutrophil Cytoplasmic , Arthritis, Rheumatoid/immunology , Female , Hemorrhage/diagnostic imaging , Hemorrhage/pathology , Humans , Lung/diagnostic imaging , Lung/pathology , Lung Diseases/diagnostic imaging , Lung Diseases/pathology , Male , Middle Aged , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...